A “Twist” In Making DNA Means Huge Growth Prospects For This Stock
The synthetic biology company discussed in today’s article is a favorite of ARK Invest CEO Cathie Wood. In fact, it’s the fifth-largest holding in her ARK Genomic Revolution ETF.
Healthcare Stocks
These 2 Coronavirus Vaccine Stocks Offer “The Best Of Both Worlds”
Of the two “best of both worlds” biotech stocks highlighted in today’s article – “companies with both solid drug-development track records and potential COVID-19 vaccine tailwinds that could net them each significant profits for their role over the next several years”.